test

Troy Wuertz

@Ikarian Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$717.154MTotal holdings121
Assets growth rate24.93%Assets growth rate (2-Q avg)-6.06%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Ikarian Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 121 positions.

Assets under management

The assets under management (AUM) of Ikarian Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 717.154M in assets, with a quarterly growth rate of 24.93% and a 2-quarter average growth rate of -6.06%. The portfolio is managed by Troy Wuertz, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
INBXInhibrx Biosciences Inc
Recent Activity
Decreased -81.68%
0.1%
$659,646
42,123 shares@ $15.66 avg price
VTYXVentyx Biosciences Inc
Recent Activity
Decreased -56.47%
0.06%
$419,970
192,647 shares@ $2.18 avg price
LRMRLarimar Therapeutics Inc
Recent Activity
Decreased -81.9%
0.06%
$383,358
58,528 shares@ $6.55 avg price
MNMDMind Medicine Mindmed Inc
Recent Activity
Decreased -61.54%
0.05%
$355,516
62,481 shares@ $5.69 avg price
RAPTRapt Therapeutics Inc
Recent Activity
Decreased -1.27%
0.05%
$310,796
154,625 shares@ $2.01 avg price
TARAProtara Therapeutics Inc
Recent Activity
Decreased -13.83%
0.04%
$284,953
155,712 shares@ $1.84 avg price
MGNXMacrogenics Inc
Recent Activity
Decreased -59.97%
0.04%
$263,460
80,079 shares@ $3.3 avg price
NUVBNuvation Bio Inc
Recent Activity
Decreased -76.75%
0.03%
$190,716
83,282 shares@ $2.3 avg price